Publication date: Mar 01, 2025
Infective and noninfective pulmonary complications occur with biologic agents and targeted small molecule inhibitors used to treat immune-mediated inflammatory conditions. The most common lower respiratory tract infection is bacterial pneumonia. Opportunistic infections including tuberculosis can also occur at increased rates depending on the immunosuppressive agent, specific disease, and epidemiologic background of the patient. The most common noninfectious sequela is drug-induced interstitial lung disease.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Complications |
| disease | MESH | Autoimmune Diseases |
| disease | MESH | bacterial pneumonia |
| disease | MESH | Opportunistic infections |
| disease | MESH | tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | MESH | interstitial lung disease |
| disease | MESH | Immunocompromised host |
| disease | MESH | Lung Diseases |
| disease | MESH | infections |